Sophonix is Diagnostic Equipment in China that focus on ultral path business. Founded in 2017. They cover business area such as developer, manufacturer, seller, diagnostic equipment, automatic chemiluminescence immunoanalyzer, ultral path, automatic immunohistochemical stain apparatus, highly sensitive and accurate testing result, doctor, accurate diagnosis.
2017
( 7 years old in 2024 )
Ultral Path
-
3/F, Unit B, Building 19, Dazu Qiyewan
Liangshuihe Second Street, Yizhuang Development District
Beijing
China
Private
developermanufacturersellerdiagnostic equipmentautomatic chemiluminescence immunoanalyzerultral pathautomatic immunohistochemical stain apparatushighly sensitive and accurate testing resultdoctoraccurate diagnosis
* We use standard office opening hours in near Sophonix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sophonix is Diagnostic Equipment business from China that founded in 2017 (7 years old in 2024), Sophonix business is focusing on Ultral Path.
Sophonix headquarter office and corporate office address is located in 3/F, Unit B, Building 19, Dazu Qiyewan Liangshuihe Second Street, Yizhuang Development District Beijing China.
Sophonix was founded in China.
In 2024, Sophonix is currently focus on ultral path sector.
Above is snippet of Google Trends for "ultral path" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sophonix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.